64.04
price up icon1.62%   1.02
after-market After Hours: 62.80 -1.24 -1.94%
loading
Haemonetics Corp stock is traded at $64.04, with a volume of 466.97K. It is up +1.62% in the last 24 hours and down -2.23% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
See More
Previous Close:
$63.02
Open:
$62.45
24h Volume:
466.97K
Relative Volume:
0.54
Market Cap:
$3.17B
Revenue:
$1.36B
Net Income/Loss:
$123.81M
P/E Ratio:
26.57
EPS:
2.41
Net Cash Flow:
$20.35M
1W Performance:
-0.33%
1M Performance:
-2.23%
6M Performance:
-19.25%
1Y Performance:
-23.92%
1-Day Range:
Value
$62.24
$64.22
1-Week Range:
Value
$62.03
$64.66
52-Week Range:
Value
$58.80
$97.97

Haemonetics Corp Stock (HAE) Company Profile

Name
Name
Haemonetics Corp
Name
Phone
(781) 848-7100
Name
Address
125 SUMMER STREET, BOSTON, MA
Name
Employee
3,657
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
HAE's Discussions on Twitter

Compare HAE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
HAE
Haemonetics Corp
64.04 3.17B 1.36B 123.81M 20.35M 2.41
Medical Devices icon
ABT
Abbott Laboratories
131.93 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.05 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
377.46 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.86 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.05 42.10B 5.72B 4.17B 259.90M 6.97

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-07-25 Downgrade BofA Securities Neutral → Underperform
Dec-06-24 Initiated JP Morgan Overweight
Nov-08-24 Upgrade Raymond James Outperform → Strong Buy
Sep-13-24 Initiated CL King Buy
Sep-11-24 Initiated BofA Securities Neutral
Sep-10-24 Initiated BTIG Research Buy
Jun-12-24 Upgrade Needham Hold → Buy
Oct-13-22 Initiated Mizuho Buy
Jan-27-22 Downgrade Needham Buy → Hold
Dec-15-21 Downgrade Citigroup Buy → Neutral
Aug-17-21 Resumed Raymond James Outperform
Jun-17-21 Initiated Citigroup Buy
May-14-21 Upgrade CJS Securities Market Perform → Market Outperform
Apr-20-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21 Downgrade CJS Securities Market Outperform → Market Perform
Feb-03-21 Upgrade Barrington Research Mkt Perform → Outperform
Jan-21-21 Downgrade Barrington Research Outperform → Mkt Perform
Nov-05-20 Upgrade Barrington Research Mkt Perform → Outperform
May-06-20 Downgrade Barrington Research Outperform → Mkt Perform
Mar-31-20 Upgrade CJS Securities Market Perform → Market Outperform
Jan-10-20 Initiated Needham Buy
Aug-07-19 Reiterated Barrington Research Outperform
May-14-19 Upgrade Raymond James Mkt Perform → Outperform
May-08-19 Reiterated Barrington Research Outperform
Aug-09-18 Reiterated Barrington Research Outperform
Feb-07-18 Reiterated Barrington Research Outperform
Jan-02-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-08-17 Reiterated Barrington Research Outperform
Aug-08-17 Upgrade Barrington Research Mkt Perform → Outperform
Jul-13-17 Upgrade JMP Securities Mkt Perform → Mkt Outperform
Feb-07-17 Downgrade Barrington Research Outperform → Mkt Perform
Nov-08-16 Upgrade Barrington Research Mkt Perform → Outperform
Nov-07-16 Reiterated The Benchmark Company Hold
Sep-20-16 Downgrade CJS Securities Market Outperform → Market Perform
Aug-15-16 Downgrade Sidoti Buy → Neutral
Aug-02-16 Reiterated Jefferies Buy
Aug-02-16 Reiterated The Benchmark Company Hold
View All

Haemonetics Corp Stock (HAE) Latest News

pulisher
Apr 01, 2025

Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now? - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 - Yahoo Finance

Mar 31, 2025
pulisher
Mar 27, 2025

10 Pro-Life Companies to Invest In Now - Insider Monkey

Mar 27, 2025
pulisher
Mar 24, 2025

A Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To Equity - Yahoo Finance

Mar 24, 2025
pulisher
Mar 21, 2025

Fractional Flow Reserve Market Set for 11.27% CAGR Growth by 2031 - openPR

Mar 21, 2025
pulisher
Mar 19, 2025

Haemonetics (NYSE:HAE) Given New $104.00 Price Target at Needham & Company LLC - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Is it Apt to Retain HAE Stock in Your Portfolio for Now? - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Demystifying Haemonetics: Insights From 5 Analyst Reviews - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Needham Trims Price Target on Haemonetics to $104 From $108, Keeps Buy Rating -March 18, 2025 at 06:53 am EDT - MarketScreener

Mar 18, 2025
pulisher
Mar 18, 2025

Haemonetics FY2025 EPS Estimate Reduced by Zacks Research - Defense World

Mar 18, 2025
pulisher
Mar 12, 2025

Haemonetics Corp (HAE) Shares Down 3.63% on Mar 12 - GuruFocus.com

Mar 12, 2025
pulisher
Mar 11, 2025

How Do Investors Really Feel About Haemonetics? - Benzinga

Mar 11, 2025
pulisher
Mar 06, 2025

Haemonetics at Raymond James Conference: Strategic Growth Insights - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Haemonetics at Raymond James Conference: Strategic Growth Insights By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 03, 2025

Haemonetics Names Chief Operating Officer, Chief Commercial Officer -March 03, 2025 at 05:40 pm EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Haemonetics appoints new executive leadershi - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Haemonetics Announces Executive Leadership Updates - Quantisnow

Mar 03, 2025
pulisher
Feb 28, 2025

Global Blood Bank Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.

Feb 28, 2025
pulisher
Feb 27, 2025

Haemonetics Corp. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 24, 2025

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Quantisnow

Feb 24, 2025
pulisher
Feb 21, 2025

Zacks Research Forecasts Haemonetics’ Q3 Earnings (NYSE:HAE) - Defense World

Feb 21, 2025
pulisher
Feb 21, 2025

Van ECK Associates Corp Buys Shares of 39,620 Haemonetics Co. (NYSE:HAE) - Defense World

Feb 21, 2025
pulisher
Feb 20, 2025

Haemonetics FY2025 EPS Forecast Decreased by Zacks Research - Defense World

Feb 20, 2025
pulisher
Feb 18, 2025

(HAE)Analyzing Haemonetics's Short Interest - Benzinga

Feb 18, 2025
pulisher
Feb 15, 2025

SG Americas Securities LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Janney Montgomery Scott LLC Invests $402,000 in Haemonetics Co. (NYSE:HAE) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Haemonetics (NYSE:HAE) Reaches New 12-Month Low After Analyst Downgrade - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Haemonetics Co. (NYSE:HAE) Given Consensus Rating of “Moderate Buy” by Brokerages - Armenian Reporter

Feb 14, 2025
pulisher
Feb 14, 2025

Haemonetics Co. (NYSE:HAE) Shares Sold by Retirement Systems of Alabama - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Haemonetics Co. (NYSE:HAE) Shares Sold by Yousif Capital Management LLC - Defense World

Feb 13, 2025
pulisher
Feb 13, 2025

Haemonetics' (NYSE:HAE) Earnings Offer More Than Meets The Eye - Yahoo Finance

Feb 13, 2025
pulisher
Feb 12, 2025

Haemonetics Co. (NYSE:HAE) Receives $101.67 Average Price Target from Analysts - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Haemonetics (NYSE:HAE) Given New $108.00 Price Target at Needham & Company LLC - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Haemonetics Co. (NYSE:HAE) Receives $101.67 Consensus Target Price from Analysts - Defense World

Feb 12, 2025
pulisher
Feb 12, 2025

Haemonetics (NYSE:HAE) Price Target Cut to $100.00 by Analysts at JMP Securities - MarketBeat

Feb 12, 2025
pulisher
Feb 11, 2025

Haemonetics (NYSE:HAE) Raised to "Buy" at StockNews.com - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Haemonetics (NYSE:HAE) Downgraded to Underperform Rating by Bank of America - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Haemonetics' (HAE) "Strong-Buy" Rating Reaffirmed at Raymond James - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Haemonetics (NYSE:HAE) Reaches New 52-Week Low After Analyst Downgrade - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Barrington Research Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World

Feb 10, 2025
pulisher
Feb 10, 2025

Haemonetics (NYSE:HAE) Upgraded at StockNews.com - Defense World

Feb 10, 2025
pulisher
Feb 10, 2025

Haemonetics (NYSE:HAE) Shares Gap Down Following Weak Earnings - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

It is Poised to be a Bull Market for Haemonetics Corp (HAE) - SETE News

Feb 10, 2025
pulisher
Feb 09, 2025

Haemonetics (HAE) Projected to Post Earnings on Thursday - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Haemonetics (NYSE:HAE) Releases FY 2025 Earnings Guidance - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Haemonetics (NYSE:HAE) Receives “Strong-Buy” Rating from Raymond James - Armenian Reporter

Feb 08, 2025
pulisher
Feb 07, 2025

Haemonetics Co. (NYSE:HAE) Sees Large Increase in Short Interest - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

Haemonetics (HAE) Q3 Earnings Meet Estimates - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Haemonetics Corp [HAE] Former Officer makes an insider purchase of 6,238 shares worth 0.57 million. - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Haemonetics' stock slides on revenue miss - MSN

Feb 07, 2025

Haemonetics Corp Stock (HAE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices STE
$227.57
price up icon 0.82%
medical_devices ZBH
$112.50
price up icon 0.12%
medical_devices PHG
$24.84
price down icon 1.55%
$68.14
price up icon 1.22%
$79.36
price down icon 0.26%
medical_devices EW
$72.05
price up icon 0.25%
Cap:     |  Volume (24h):